Zealand Pharma A/S (ZLDPF)
48.24
-2.27
(-4.49%)
USD |
OTCM |
Aug 24, 16:00
Zealand Pharma Total Assets (Quarterly) : 3.023B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.023B |
| March 31, 2026 | 2.359B |
| December 31, 2025 | 2.588B |
| September 30, 2025 | 2.644B |
| June 30, 2025 | 2.703B |
| March 31, 2025 | 1.321B |
| December 31, 2024 | 1.534B |
| September 30, 2024 | 1.442B |
| June 30, 2024 | 1.460B |
| March 31, 2024 | 519.34M |
| December 31, 2023 | 474.02M |
| September 30, 2023 | 308.88M |
| June 30, 2023 | 300.33M |
| March 31, 2023 | 195.51M |
| December 31, 2022 | 367.98M |
| September 30, 2022 | 143.82M |
| June 30, 2022 | 176.65M |
| March 31, 2022 | 274.84M |
| December 31, 2021 | 316.14M |
| September 30, 2021 | 258.83M |
| June 30, 2021 | 306.86M |
| March 31, 2021 | 342.90M |
| December 31, 2020 | 289.63M |
| September 30, 2020 | 324.39M |
| June 30, 2020 | 342.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 229.62M |
| December 31, 2019 | 240.28M |
| September 30, 2019 | 250.21M |
| June 30, 2019 | 187.58M |
| March 31, 2019 | 203.13M |
| December 31, 2018 | 188.39M |
| September 30, 2018 | 237.23M |
| June 30, 2018 | 81.82M |
| March 31, 2018 | 100.59M |
| December 31, 2017 | 116.33M |
| September 30, 2017 | 131.64M |
| June 30, 2017 | 58.46M |
| March 31, 2017 | 68.20M |
| December 31, 2016 | 98.53M |
| September 30, 2016 | 85.98M |
| June 30, 2016 | 71.30M |
| March 31, 2016 | 106.25M |
| December 31, 2015 | 92.39M |
| September 30, 2015 | 80.16M |
| June 30, 2015 | 77.19M |
| March 31, 2015 | 81.83M |
| December 31, 2014 | 96.97M |
| September 30, 2014 | 60.71M |
| June 30, 2014 | 61.17M |
| March 31, 2014 | 70.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Genmab A/S | 12.51B |
| Ascendis Pharma A/S | 2.614B |
| Bavarian Nordic A/S | 2.252B |
| Evaxion AS | 19.38M |
| Novo Nordisk A/S | 91.00B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 269.50M |
| Shareholders Equity (Quarterly) | 2.753B |
| Debt to Equity Ratio | 0.0228 |
| Current Ratio | 13.98 |
| Net Debt Paydown Yield | -0.04% |